Bae WK - Search Results

1

Bae WK, Chung IJ. Bae WK, et al. Korean J Intern Med. 2018 Nov;33(6):1258-1259. doi: 10.3904/kjim.2012.092. Epub 2017 Nov 24. Korean J Intern Med. 2018. PMID: 29166761 Free PMC article. No abstract available.

2

Polymyositis and myocarditis after donor lymphocyte infusion.

Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, Lee JJ, Chung IJ, Juhng SW, Kim HJ. Ahn JS, et al. Among authors: bae wk. Int J Hematol. 2009 Jul;90(1):113-116. doi: 10.1007/s12185-009-0332-3. Epub 2009 May 27. Int J Hematol. 2009. PMID: 19472035

3

Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.

Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ. Lee SJ, et al. Among authors: bae wk. Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29. Cancer Chemother Pharmacol. 2009. PMID: 19479256 Clinical Trial.

4

Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.

Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, Chung WK, Chung IJ. Bae WK, et al. Cancer Chemother Pharmacol. 2010 Feb;65(3):589-95. doi: 10.1007/s00280-009-1152-0. Cancer Chemother Pharmacol. 2010. PMID: 19830427 Clinical Trial.

5

Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.

Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ. Shim HJ, et al. Among authors: bae wk. Am J Clin Oncol. 2010 Dec;33(6):624-8. doi: 10.1097/COC.0b013e3181bead92. Am J Clin Oncol. 2010. PMID: 20142726 Clinical Trial.

6

Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.

Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Yang DH, et al. Among authors: bae wk. Ann Hematol. 2010 Aug;89(8):795-801. doi: 10.1007/s00277-010-0931-3. Epub 2010 Mar 18. Ann Hematol. 2010. PMID: 20238114

7

Intratumoral administration of anti-KITENIN shRNA-loaded PEI-alt-PEG nanoparticles suppressed colon carcinoma established subcutaneously in mice.

Park IK, Kim KK, Cho SH, Bae WK, Jere D, Cho CS, Chung IJ. Park IK, et al. Among authors: bae wk. J Nanosci Nanotechnol. 2010 May;10(5):3280-3. doi: 10.1166/jnn.2010.2231. J Nanosci Nanotechnol. 2010. PMID: 20358939

8

Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity.

Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ. Ahn JS, et al. Among authors: bae wk. Cancer Res Treat. 2010 Mar;42(1):37-41. doi: 10.4143/crt.2010.42.1.37. Epub 2010 Mar 31. Cancer Res Treat. 2010. PMID: 20369050 Free PMC article.

9

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor.

Hwang JE, Yoon JY, Bae WK, Shim HJ, Cho SH, Chung IJ. Hwang JE, et al. Among authors: bae wk. BMC Cancer. 2010 Aug 18;10:438. doi: 10.1186/1471-2407-10-438. BMC Cancer. 2010. PMID: 20718969 Free PMC article.

10

Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.

Bae WK, Umeyama A, Chung IJ, Lee JJ, Takei M. Bae WK, et al. Cell Immunol. 2010;266(1):104-10. doi: 10.1016/j.cellimm.2010.09.004. Epub 2010 Sep 18. Cell Immunol. 2010. PMID: 20933226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page